(4aS,4bR,10bS,12aS)-8-(benzyloxy)-12a-methyl-4,4a,5,6,10b,11,12,12a-octahydro-1H-naphtho[2,1-f]isochromen-3(4bH)-one

ID: ALA3754790

Chembl Id: CHEMBL3754790

PubChem CID: 102531370

Max Phase: Preclinical

Molecular Formula: C25H28O3

Molecular Weight: 376.50

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@]12CC[C@@H]3c4ccc(OCc5ccccc5)cc4CC[C@H]3[C@@H]1CC(=O)OC2

Standard InChI:  InChI=1S/C25H28O3/c1-25-12-11-21-20-10-8-19(27-15-17-5-3-2-4-6-17)13-18(20)7-9-22(21)23(25)14-24(26)28-16-25/h2-6,8,10,13,21-23H,7,9,11-12,14-16H2,1H3/t21-,22-,23+,25-/m1/s1

Standard InChI Key:  YXTIDKKHEWTDAM-AGDMDRQQSA-N

Associated Targets(non-human)

Cyp19a1 Cytochrome P450 19A1 (290 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 376.50Molecular Weight (Monoisotopic): 376.2038AlogP: 5.27#Rotatable Bonds: 3
Polar Surface Area: 35.53Molecular Species: NEUTRALHBA: 3HBD:
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 5.37CX LogD: 5.37
Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.68Np Likeness Score: 1.20

References

1. Yadav MR, Barmade MA, Tamboli RS, Murumkar PR..  (2015)  Developing steroidal aromatase inhibitors-an effective armament to win the battle against breast cancer.,  105  [PMID:26469743] [10.1016/j.ejmech.2015.09.038]

Source